ロボット支援による脳幹出血に対する低侵襲手術 (RAINBOW-BSH)
ロボティクスを活用した脳幹出血に対する低侵襲手術戦略の研究
The purpose of this clinical trial is to observe the improvements in clinical symptoms and imaging outcomes for brainstem hemorrhage using robot-assisted stereotactic puncture, evaluate the clinical efficacy and safety of this treatment, and explore the development of a high-precision, intelligent, and individualized microsurgical diagnosis and treatment process for brainstem hemorrhage. The main questions it aims to address are:
- Establish a multi-center clinical database for brainstem hemorrhage.
- Clinically observe and evaluate the intervention effects of robot-assisted stereotactic puncture on brainstem hemorrhage, compare it with the traditional conservative treatment control group, and investigate its efficacy and impact on patient survival, motor evoked potentials, and the degree of neurological deficits.
- Optimize the Artificial Intelligence (AI) algorithm-based robotic surgical assistance system, and explore the prediction of preoperative brainstem hematoma stability and hematoma path planning.
Participants in the experimental group will:
- Undergo robot-assisted stereotactic minimally invasive surgery for brainstem hematoma puncture
- Receive conservative non-surgical treatment.
If there is a control group: the researchers will compare the conservative non-surgical treatment group to evaluate the effectiveness of robot-assisted stereotactic minimally invasive surgery for brainstem hematoma puncture.
調査の概要
状態
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Yanbing Yu, M.D.
- 電話番号:+86-13901114963
- メール:yuyanbing123@126.com
研究連絡先のバックアップ
- 名前:Yulian Zhang, M.D.
- 電話番号:+86-13051581507
- メール:398824625@qq.com
研究場所
-
-
Beijing Municipality
-
Beijing、Beijing Municipality、中国、100029
- 募集
- China-Japan Friendship Hospital
-
コンタクト:
- Yulian Zhang, M.D.
- 電話番号:+86-13051581507
- メール:398824625@qq.com
-
コンタクト:
- Yanbing Yu, M.D.
- 電話番号:13901114963
- メール:yuyanbing123@126.com
-
副調査官:
- Xu Yang, M.D.
-
Beijing、Beijing Municipality、中国、100049
- 募集
- Aerospace Center Hospital
-
コンタクト:
- Feng Yin, M.D.
- 電話番号:+86-13381207600
- メール:yinf897@163.com
-
コンタクト:
- Hui Chen, M.D.
- 電話番号:+86-13810520648
- メール:16564583@qq.com
-
-
Guangxi
-
Nanning、Guangxi、中国、530021
- 募集
- The First Affiliated Hospital of Guangxi Medical University
-
コンタクト:
- DAQIN FENG
- 電話番号:+8619914884494
- メール:13807713918@163.com
-
-
Hebei
-
Shijiazhuang、Hebei、中国、100190
- 募集
- Hebei Provincial People's Hospital
-
コンタクト:
- Tao Qian, M.D.
- 電話番号:+86-15931423666
- メール:qt1966a@163.com
-
コンタクト:
- Yang Li, M.D.
- 電話番号:+86-18632109423
- メール:772355464@qq.com
-
-
Jiangsu
-
Nanjing、Jiangsu、中国、210008
- 募集
- Nanjing Drum Tower Hospital
-
コンタクト:
- CHUNHUA HANG
- 電話番号:+8613813379309
- メール:hang1965@nju.edu.cn
-
Nantong、Jiangsu、中国、226001
- 募集
- Affiliated Hospital of Nantong University
-
コンタクト:
- JIANHONG SHEN
- 電話番号:+8613506287516
- メール:tysjh@163.com
-
-
Jiangxi
-
Nanchang、Jiangxi、中国、330006
- 募集
- The Second Affiliated Hospital of Nanchang University
-
コンタクト:
- HUA GUO
- 電話番号:+8613697081718
- メール:ndefy02014@ncu.edu.cn
-
-
Shanghai Municipality
-
Shanghai、Shanghai Municipality、中国、200040
- 募集
- Huashan Hospital Fudan University
-
コンタクト:
- JIN HU
- 電話番号:+8618930174565
- メール:hujin@fudan.edu.cn
-
Shanghai、Shanghai Municipality、中国、201199
- 募集
- Shanghai Minhang District Central Hospital
-
コンタクト:
- FULIN XU
- 電話番号:+8618121270156
- メール:18918169183@163.com
-
Shanghai、Shanghai Municipality、中国、200120
- 募集
- Shanghai East Hospital, Tongji University
-
コンタクト:
- CHUNLONG ZHONG
- 電話番号:+8613917920669
- メール:drchunlongzhong@tongji.edu.cn
-
Shanghai、Shanghai Municipality、中国、201508
- 募集
- Jinshan Hospital, Fudan University
-
コンタクト:
- ERSONG WANG
- 電話番号:wersong@aliyun +8618930815670
-
-
Tianjin Municipality
-
Tianjin、Tianjin Municipality、中国、300350
- 募集
- Tianjin Huanhu Hospital
-
コンタクト:
- JIE ZUO
- 電話番号:+8618920195507
- メール:luckywhg@163.com
-
-
Zhejiang
-
Hangzhou、Zhejiang、中国、310009
- 募集
- The Second Affiliated Hospital of Zhejiang University School of Medicine
-
コンタクト:
- Gao Chen
- 電話番号:+8613738194475
- メール:d-chengao@zju.edu.cn
-
Jinhua、Zhejiang、中国、321000
- 募集
- Jinhua Municipal Central Hospital / Jinhua Hospital Affiliated to Zhejiang University School of Medicine
-
コンタクト:
- MINFENG TONG
- 電話番号:+8613646694178
- メール:Tmfhyj@sina.com
-
Wenzhou、Zhejiang、中国、325000
- 募集
- The First Affiliated Hospital of Wenzhou Medical University
-
コンタクト:
- QUN LI
- 電話番号:+8615858002900
- メール:garylina@126.com
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Participants must meet all of the following inclusion criteria:
- Age ≥18 years at randomization;
- Diagnosed with brainstem hemorrhage via imaging (CT, CTA, etc.);
- Hematoma volume ≥3 mL;
- Glasgow Coma Scale (GCS) score of 3-12;
- Available for surgery within 48 hours after onset;
- Modified Rankin Scale (mRS) score ≤ 1 prior to this hemorrhage;
- Informed consent obtained in accordance with national laws, regulations, and applicable ethics committee requirements.
Patients will be excluded if they meet any of the following criteria:
- Hematoma involving other regions such as the supratentorial compartment, basal ganglia, thalamus, midbrain, or ventricles.
- Radiologically confirmed cerebral vascular abnormalities including ruptured aneurysms, arteriovenous malformations (AVMs), or Moyamoya disease; hemorrhagic transformation of ischemic infarcts; or recent (within 1 year) recurrence of intracerebral hemorrhage;
- Any irreversible coagulation disorder or known coagulopathy; platelet count <100,000/µL; INR >1.4; or use of anticoagulant medication within 7 days before the current hemorrhage;
- Current or probable pregnancy;
- Patients with concurrent severe illness likely to influence outcome assessment;
- Difficulty in follow-up or poor compliance due to any cause.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Robot-assisted minimally invasive puncture and aspiration surgery
The intervention group will receive robot-assisted stereotactic puncture for brainstem hemorrhage |
Positioning and surgical operation will be performed according to the robot navigation system protocols. Preoperative imaging data will be used for precise surgical planning, including the construction of a three-dimensional (3D) preoperative visualization model. The 3D reconstruction and CT data will be imported into the AI robot-assisted stereotactic system, which, after mapping to the patient's skull, automatically designs the surgical target, calculates coordinate values, plans the puncture trajectory, and determines the cranial entry point. Different surgical approaches will be selected based on the location and shape of the hematoma, and individualized parameters, including puncture direction and trajectory length, will be generated for each patient. During the procedure, the robot will assist with stereotactic puncture, while the patient's heart rate and blood pressure are closely monitored.
他の名前:
According to the "Chinese Neurosurgical Expert Consensus on the Diagnosis and Treatment of Primary Brainstem Hemorrhage", conventional medical treatment includes oxygen therapy, specialized nursing care, blood pressure control (maintaining BP at ≤140/90 mmHg), sedation, intracranial pressure reduction, arousal promotion, gastric protection, maintenance of internal homeostasis, infection prevention, neuro-nutrition, brain function support, nutritional support, and overall systemic management; For comatose patients, ensure a patent airway, provide nebulization and sputum clearance, prevent respiratory depression, and improve respiratory function. Closely monitor the patient's condition and provide active symptomatic treatment as needed. Regular cranial CT scans are performed to evaluate intracranial status, and in cases of ventricular hemorrhage or obstructive hydrocephalus, lateral ventricular puncture and drainage may be performed.
他の名前:
|
|
アクティブコンパレータ:Standard medical management
The control group will undergo conventional medical conservative management. |
According to the "Chinese Neurosurgical Expert Consensus on the Diagnosis and Treatment of Primary Brainstem Hemorrhage", conventional medical treatment includes oxygen therapy, specialized nursing care, blood pressure control (maintaining BP at ≤140/90 mmHg), sedation, intracranial pressure reduction, arousal promotion, gastric protection, maintenance of internal homeostasis, infection prevention, neuro-nutrition, brain function support, nutritional support, and overall systemic management; For comatose patients, ensure a patent airway, provide nebulization and sputum clearance, prevent respiratory depression, and improve respiratory function. Closely monitor the patient's condition and provide active symptomatic treatment as needed. Regular cranial CT scans are performed to evaluate intracranial status, and in cases of ventricular hemorrhage or obstructive hydrocephalus, lateral ventricular puncture and drainage may be performed.
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Survival rate
時間枠:60 days
|
60 days survival rate after follow-up |
60 days
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Ordinal shift in mRS scores at 60 days and 6 months
時間枠:60 days and 6 months
|
The modified Rankin Scale (mRS) is a standardized tool used to assess the neurological recovery status of stroke patients. The scale is divided into seven levels, ranging from 0 to 6. Higher scores indicate more severe patient conditions. |
60 days and 6 months
|
|
Favorable functional outcome at 60 days and 6 months (mRS 0-1)
時間枠:60 days and 6 months
|
The modified Rankin Scale (mRS) is a standardized tool used to assess the neurological recovery status of stroke patients. The scale is divided into seven levels, ranging from 0 to 6. Higher scores indicate more severe patient conditions. |
60 days and 6 months
|
|
Functional independence at 60 days and 6 months (mRS 0-2)
時間枠:60 days and 6 months
|
The modified Rankin Scale (mRS) is a standardized tool used to assess the neurological recovery status of stroke patients. The scale is divided into seven levels, ranging from 0 to 6. Higher scores indicate more severe patient conditions. |
60 days and 6 months
|
|
Health-related quality of life (HRQoL) at 60 days and 6 months, assessed by the EQ-5D-5L questionnaire
時間枠:60 days and 6 months
|
Health-related quality of life (HRQoL) at 60 days and 6 months, assessed by the EQ-5D-5L questionnaire |
60 days and 6 months
|
|
Utility-weighted mRS at 60 days and 6 months
時間枠:60 days and 6 months
|
The modified Rankin Scale (mRS) is a standardized tool used to assess the neurological recovery status of stroke patients. The scale is divided into seven levels, ranging from 0 to 6. Higher scores indicate more severe patient conditions. |
60 days and 6 months
|
|
Cognitive function at 60 days and 6 months
時間枠:60 days and 6 months
|
Cognitive function at 60 days and 6 months |
60 days and 6 months
|
|
Total length of hospital stay
時間枠:60 days
|
Total length of hospital stay |
60 days
|
|
Costs during hospitalization
時間枠:60 days
|
Costs during hospitalization |
60 days
|
|
ICU length of stay
時間枠:60 days
|
ICU length of stay |
60 days
|
|
Brainstem hematoma clearance rate on postoperative days 1, 3, and 7
時間枠:1, 3, and 7 days
|
The change in hematoma volume compared to the preoperative CT scan was assessed 1, 3, and 7 days postoperatively. |
1, 3, and 7 days
|
|
Incidence of related complications within 14 days, including pneumonia, aphasia, seizures, and lower-extremity deep vein thrombosis
時間枠:14 days
|
Incidence of related complications within 14 days, including pneumonia, aphasia, seizures, and lower-extremity deep vein thrombosis |
14 days
|
協力者と研究者
スポンサー
捜査官
- スタディチェア:Yanbing Yu, M.D.、China-Japan Friendship Hospital
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。